{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T06:10:22Z","timestamp":1685081422882},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T00:00:00Z","timestamp":1248998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"},{"start":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T00:00:00Z","timestamp":1248998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthopaed Traumatol"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-weight-bearing, pre- and postsurgical immobilization, neoadjuvant and adjuvant chemotherapy are known to act on bone turnover, causing osteoporosis over short and long time periods. Treatment of fracture insurgence is very difficult because it really depends on being able to choose the right time (i.e., when immunodeficiency is less important). We report a case of spontaneous neck femur fracture during adjuvant chemotherapy in a young girl treated with resection and prosthesis reconstruction for distal femur osteosarcoma. Possible prevention and the correct approach and surgical timing are emphasized considering immunodeficiency following chemotherapy.<\/jats:p>","DOI":"10.1007\/s10195-009-0059-1","type":"journal-article","created":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T15:59:39Z","timestamp":1248969579000},"page":"151-154","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An osteoporotic hip fracture in a 14-year-old girl undergoing chemotherapy and operated for knee osteosarcoma"],"prefix":"10.1007","volume":"10","author":[{"given":"Carmine","family":"Zoccali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Prencipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Ferraresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Salducca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,31]]},"reference":[{"key":"59_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00043426-199805000-00010","volume":"20","author":"J Aisenberg","year":"1998","unstructured":"Aisenberg J, Hsieh K, Kalaitzoglou G, Whittam E, Heller G, Schneider R, Sklar C (1998) Bone mineral density in young adult survivors of childhood cancer. J Pediatr Hematol Oncol 20:241\u2013245","journal-title":"J Pediatr Hematol Oncol"},{"key":"59_CR2","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1210\/jcem.84.9.5968","volume":"84","author":"P Arikoski","year":"1999","unstructured":"Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, Kroger H (1999) Alterations of bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study. J Clin Endocrinol Metab 84:3174\u20133181","journal-title":"J Clin Endocrinol Metab"},{"key":"59_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00043426-199611000-00006","volume":"18","author":"RC Henderson","year":"1996","unstructured":"Henderson RC, Madsen CD, Davis C, Gold SH (1996) Bone density in survivors of childhood malignancies. J Pediatr Hematol Oncol 18:367\u2013371","journal-title":"J Pediatr Hematol Oncol"},{"key":"59_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/00043426-199807000-00008","volume":"20","author":"RC Henderson","year":"1998","unstructured":"Henderson RC, Madsen CD, Davis C, Gold SH (1998) Longitudinal evaluation of bone mineral density in children receiving chemotherapy. J Pediatr Hematol Oncol 20:322\u2013326","journal-title":"J Pediatr Hematol Oncol"},{"key":"59_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/01.mph.0000162526.77400.78","volume":"27","author":"J Kelly","year":"2005","unstructured":"Kelly J, Damron T, Grant W, Anker C, Holdridge S, Shaw S, Horton J, Cherrick I, Spadaro J (2005) Cross-sectional study of bone mineral density in adult survivors of solid pediatric cancers. J Pediatr Hematol Oncol 27:248\u2013253","journal-title":"J Pediatr Hematol Oncol"},{"key":"59_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/(SICI)1096-911X(199904)32:4<272::AID-MPO6>3.0.CO;2-G","volume":"32","author":"R Vassilopoulou-Sellin","year":"1999","unstructured":"Vassilopoulou-Sellin R, Brosnan P, Delpassand A, Zietz H, Klein MJ, Jaffe N (1999) Osteopenia in young adult survivors of childhood cancer. Med Pediatr Oncol 32:272\u2013278","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"59_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1148\/radiology.202.2.9015088","volume":"202","author":"K Ecklund","year":"1997","unstructured":"Ecklund K, Laor T, Goorin AM, Connolly LP, Jaramillo D (1997) Methotrexate osteopathy in patients with osteosarcoma. Radiology 202(2):543\u2013547","journal-title":"Radiology"},{"issue":"4","key":"59_CR8","first-page":"1971","volume":"22","author":"P Virolainen","year":"2002","unstructured":"Virolainen P, Inoue N, Nagao M, Frassica FJ, Chao EY (2002) The effect of a doxorubicin, cisplatin and ifosfamide combination chemotherapy on bone turnover. Anticancer Res 22(4):1971\u20131975","journal-title":"Anticancer Res"},{"issue":"10 Suppl","key":"59_CR9","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1002\/1097-0142(19930515)71:10+<3386::AID-CNCR2820711742>3.0.CO;2-7","volume":"71","author":"JP Neglia","year":"1993","unstructured":"Neglia JP, Nesbit ME Jr (1993) Care and treatment of long-term survivors of childhood cancer. Cancer 71(10 Suppl):3386\u20133391","journal-title":"Cancer"},{"issue":"7","key":"59_CR10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.2000.18.7.1570","volume":"18","author":"J Pfeilschifter","year":"2000","unstructured":"Pfeilschifter J, Diel IJ (2000) Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol 18(7):1570\u20131593","journal-title":"J Clin Oncol"},{"issue":"34","key":"59_CR11","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1200\/JCO.2004.00.5785","volume":"23","author":"S Ferrari","year":"2005","unstructured":"Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, M\u00fcller C, Tienghi A, Wiebe T, Comandone A, B\u00f6hling T, Del Prever AB, Brosj\u00f6 O, Bacci G, Saeter G, Italian, Scandinavian Sarcoma Groups (2005) Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 23(34):8845\u20138852","journal-title":"J Clin Oncol"},{"issue":"2","key":"59_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1179\/joc.2002.14.2.198","volume":"14","author":"G Bacci","year":"2002","unstructured":"Bacci G, Ferrari S, Longhi A, Picci P, Mercuri M, Alvegard TA, Saeter G, Donati D, Manfrini M, Lari S, Briccoli A, Forni C, Italian Sarcoma Group\/Scandinavian Sarcoma Group (2002) High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group\/Scandinavian Sarcoma Group pilot study. J Chemother 14(2):198\u2013206","journal-title":"J Chemother"},{"key":"59_CR13","doi-asserted-by":"crossref","unstructured":"Campanacci M (1999) Bone and soft tissue tumors, 2nd edn. Springer, New York","DOI":"10.1007\/978-3-7091-3846-5"},{"issue":"2","key":"59_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1302\/0301-620X.85B2.13257","volume":"85","author":"G Holzer","year":"2003","unstructured":"Holzer G, Krepler P, Koschat MA, Grampp S, Dominkus M, Kotz R (2003) Bone mineral density in long-term survivors of highly malignant osteosarcoma. J Bone Jt Surg Br 85(2):231\u2013237","journal-title":"J Bone Jt Surg Br"},{"key":"59_CR15","first-page":"131","volume":"84","author":"C Ripamonti","year":"1993","unstructured":"Ripamonti C, Avella M, GNudi S, Figus E (1993) Effect of high and low doses of methotrexate (MTX) on bone mass in subjects treated for osteosarcoma of the limb. Minerva Med 84:131\u2013134","journal-title":"Minerva Med"},{"issue":"5","key":"59_CR16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.bone.2007.07.021","volume":"41","author":"CJ Xian","year":"2007","unstructured":"Xian CJ, Cool JC, Scherer MA, Macsai CE, Fan C, Covino M, Foster BK (2007) Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects. Bone 41(5):842\u2013850","journal-title":"Bone"},{"issue":"12","key":"59_CR17","first-page":"2156","volume":"23","author":"P Rooney","year":"1996","unstructured":"Rooney P (1996) Methotrexate osteopathy. J Rheumatol 23(12):2156\u20132159","journal-title":"J Rheumatol"},{"key":"59_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/adc.71.4.346","volume":"71","author":"J De Schepper","year":"1994","unstructured":"De Schepper J, Hachimi-Idrissi S, Louis O, Maurus R, Otten J (1994) Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide. Arch Dis Child 71:346\u2013348","journal-title":"Arch Dis Child"},{"key":"59_CR19","first-page":"277","volume":"14","author":"S Gnudi","year":"1988","unstructured":"Gnudi S, Butturini L, Ripamonti C, Avella M, Bacci G (1988) The effects of methotrexate (MTX) on bone: a densitometric study conducted on 59 patients with MTX administered at different doses. Ital J Orthop Traumatol 14:277\u2013331","journal-title":"Ital J Orthop Traumatol"},{"issue":"2 Suppl 4","key":"59_CR20","first-page":"68","volume":"17","author":"KH Antman","year":"1990","unstructured":"Antman KH, Elias A, Ryan L (1990) Ifosfamide and mesna: response and toxicity at standard-and high-dose schedules. Semin Oncol 17(2 Suppl 4):68\u201373","journal-title":"Semin Oncol"},{"key":"59_CR21","first-page":"80","volume":"19","author":"H Fleisch","year":"1998","unstructured":"Fleisch H (1998) Bisphosphonates: mechanisms of action. J Clin Endocrinol Metab 19:80\u2013100","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"59_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/MPH.0b013e318142b7a1","volume":"29","author":"C Lethaby","year":"2007","unstructured":"Lethaby C, Wiernikowski J, Sala A, Naronha M, Webber C, Barr RD (2007) Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience. J Pediatr Hematol Oncol 29(9):613\u2013616","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Journal of Orthopaedics and Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10195-009-0059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10195-009-0059-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10195-009-0059-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10195-009-0059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T05:48:16Z","timestamp":1685080096000},"score":1,"resource":{"primary":{"URL":"https:\/\/jorthoptraumatol.springeropen.com\/articles\/10.1007\/s10195-009-0059-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,31]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s10195-009-0059-1","relation":{},"ISSN":["1590-9921","1590-9999"],"issn-type":[{"value":"1590-9921","type":"print"},{"value":"1590-9999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,31]]},"assertion":[{"value":"15 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}